DRY EYE IN AUTOIMMUNE DISEASE (RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOUS)
Main Article Content
Keywords
dry eye disease, autoimmune, rheumatoid arthritis, systemic lupus erythematosus
Abstract
Background: Autoimmune diseases are systemic disorders that involve many organs, including the eyes, and play an important role in dry eyes. This review aims to elucidate the relationship between dry eye disease (DED) and autoimmune disease.
Methods: This literature review utilized a database from 2020 until 2024. The keywords “dry eye disease”, “autoimmune", “rheumatoid arthritis", and “systemic lupus erythematous” were used to collect 9 journals that had relevant topics.
Results: Autoimmune diseases such as RA and SLE can cause DED through abnormal immune response mechanisms and inflammatory factors that harm the lacrimal glands, conjunctival membranes, corneas, and meibomian glands, resulting in tissue damage and dysfunction. This can lead to a decrease in the volume of tears and faster evaporation, resulting in DED.
Conclusion: This research shows a relationship between the incidence of DED and autoimmune diseases, including RA and SLE. Therefore, even in the absence of specific eye complaints, it is important to conduct examinations related to dry eyes in patients with autoimmune conditions.
References
2. Craig JP, Nichols KK, Akpek EK, et al. The Ocular Surface TFOS DEWS II De fi nition and Classi fi cation Report. 2017;15:276–283. doi:10.1016/j.jtos.2017.05.008
3. Golden MI, Meyer JJ, Patel BC. Dry Eye Syndrome. In: ; 2023.
4. Kemeny-Beke A, Szodoray P. Ocular manifestations of rheumatic diseases. Int Ophthalmol. 2020;40(2):503–510. doi:10.1007/s10792-019-01183-9
5. Qian L, Wei W. Identified risk factors for dry eye syndrome: A systematic review and meta-analysis. PLoS One. 2022;17(8):e0271267. doi:10.1371/journal.pone.0271267
6. Stapleton F, Alves M, Bunya VY, et al. The Ocular Surface TFOS DEWS II Epidemiology Report. Ocul Surf. 2017;15(3):334–365. doi:10.1016/j.jtos.2017.05.003
7. Alrabghi DA, Abudungor RL, Alsulaiman YS, Najjar A, Al-Manjoumi AM. Prevalence and Associated Risk Factors of Dry Eye Disease Among Children and Adults in Saudi Arabia: A Cross-Sectional Study. Cureus. 2023;2023(6):4–11. doi:10.7759/cureus.40170
8. Vehof J, Snieder H, Jansonius N, Hammond CJ. Prevalence and risk factors of dry eye in 79,866 participants of the population-based Lifelines cohort study in the Netherlands. Ocul Surf. 2021;19(November 2019):83–93. doi:10.1016/j.jtos.2020.04.005
9. García-Marqués JV, Talens-Estarelles C, García-Lázaro S, Wolffsohn JS, Cerviño A. Systemic, environmental and lifestyle risk factors for dry eye disease in a mediterranean caucasian population. Contact Lens Anterior Eye. 2022;45(5). doi:10.1016/j.clae.2021.101539
10. Ma W, Wang G, Li X, et al. Study of Factors Influencing Dry Eye in Rheumatoid Arthritis. J Ophthalmol. 2020;2020. doi:10.1155/2020/5768679
11. Abd-Allah NM, Hassan AA, Omar G, et al. Dry eye in rheumatoid arthritis: relation to disease activity. Immunol Med. 2020;43(2):92–97. doi:10.1080/25785826.2020.1729597
12. Yu K, Bunya V, Maguire M, Asbell P, Ying G-S. Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study. Ophthalmology. 2021;128(10):1384–1392. doi:https://doi.org/10.1016/j.ophtha.2021.03.030
13. Ren Y, Tian J, Shi W, et al. Evaluation and correlation analysis of ocular surface disorders and quality of life in autoimmune rheumatic diseases: a cross-sectional study. BMC Ophthalmol. 2023;23(1):229. doi:10.1186/s12886-023-02959-5
14. Eldaly ZH, Saad SA, Hammam N. Ocular surface involvement in patients with rheumatoid arthritis: Relation with disease activity and duration. Egypt Rheumatol. 2020;42(1):5–9. doi:10.1016/j.ejr.2019.05.004
15. Wang L, Xie Y, Deng Y. Prevalence of dry eye in patients with systemic lupus erythematosus: a meta-analysis. BMJ Open. 2021;11(9):e047081. doi:10.1136/bmjopen-2020-047081
16. Tseng C-H, Tai Y-H, Hong C-T, et al. Systemic Lupus Erythematosus and Risk of Dry Eye Disease and Corneal Surface Damage: A Population-Based Cohort Study. Int J Environ Res Public Health. 2023;20(5). doi:10.3390/ijerph20053776
17. Hsu CS, Hsu CW, Lu MC, Koo M. Risks of ophthalmic disorders in patients with systemic lupus erythematosus - A secondary cohort analysis of population-based claims data. BMC Ophthalmol. 2020;20(1):1–10. doi:10.1186/s12886-020-01360-w
18. Gu Z, Lu Q, Zhang A, Shuai ZW, Liao R. Analysis of Ocular Surface Characteristics and Incidence of Dry Eye Disease in Systemic Lupus Erythematosus Patients Without Secondary Sjögren’s Syndrome. Front Med. 2022;9(March):1–9. doi:10.3389/fmed.2022.833995
19. Mahmoud MSED, Hamid MA, Abdelkader MF. Anterior segment optical coherence tomography of tear film and cornea in systemic lupus erythematosus patients. Clin Ophthalmol. 2021;15:3391–3399. doi:10.2147/OPTH.S323673
20. Schjerven M, Moschowits E, Kaurstad M, et al. The Ocular Surface Greater adherence to a mediterranean diet is associated with lower C-reactive protein ( CRP ) levels , but not to lower odds of having dry eye disease. Ocul Surf. 2023;30(August):196–203. doi:10.1016/j.jtos.2023.09.013
21. Zhao S, Xiao Y, Zhang S, Liu L. Elevated Rheumatoid Factor Associates with Dry Eye in Patients with Common Autoimmune Diseases. 2022;(April):2789–2794.
22. Tsubota K, Yokoi N, Shimazaki J, et al. New Perspectives on Dry Eye Definition and Diagnosis: A Consensus Report by the Asia Dry Eye Society. Ocul Surf. 2017;15(1):65-76.
23. Aggarwal R, Ringold S, Khanna D, Neogi T, Johnson SR, Miller A, et al. Distinctions between diagnostic and classification criteria? Arthritis Care Res. 2015;67(7):891–7.
24. Barabino S, Dana MR. Dry Eye Syndromes. In: Smolin G, Thoft RA, editors. The Cornea: Scientific Foundations & Clinical Practice. 4th edition. Philadelphia: Lippincott Williams & Wilkins; 2005. Chapter 10.
25. Pflugfelder SC, Stern ME. Mucosal Environmental Sensors in the Pathogenesis of Dry Eye. Expert Rev Clin Immunol. 2014;10(9):1137-1140.
26. Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, et al. TFOS DEWS II Pathophysiology Report. Ocul Surf. 2017;15(3):438–510.
27. Belmonte C, Nichols JJ, Cox SM, Brock JA, Begley CG, Bereiter DA, et al. TFOS DEWS II Pain and Sensation Report. Ocul Surf. 2017;15(3):404–37.
28. Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, Bosch X. Primary Sjögren syndrome. BMJ. 2012;344:e3821.
29. Fox RI, Stern M. Sjögren’s syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systems. Scand J Rheumatol Suppl. 2002;116:3-13.
30. Sisto M, Lorusso L, Ingravallo G, et al. A correlation between ocular surface and dry eye tests in office workers. J Occup Med Toxicol. 2009;4:24.
31. Gilbard JP, Farris RL, Santamaria J. Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch Ophthalmol. 1978;96(4):677-681.
32. Toker E, Yavas GF, Toker MI, et al. Tear film osmolarity in patients with untreated new-onset systemic lupus erythematosus. Lupus. 2013;22(7):669-676.
33. DeSanto J, Cullen JF. Dry eyes: a common finding in SLE patients. J Rheumatol. 1982;9(4):571-573.